Literature DB >> 12795734

Physician and patient factors associated with ordering a colon evaluation after a positive fecal occult blood test.

Barbara Turner1, Ronald E Myers, Terry Hyslop, Walter W Hauck, David Weinberg, Timothy Brigham, James Grana, Todd Rothermel, Neil Schlackman.   

Abstract

OBJECTIVE: Successful colorectal cancer screening relies in part on physicians ordering a complete diagnostic evaluation of the colon (CDE) with colonoscopy or barium enema plus sigmoidoscopy after a positive screening fecal occult blood test (FOBT).
DESIGN: We surveyed primary care physicians about colorectal cancer screening practices, beliefs, and intentions. At least 1 physician responded in 318 of 413 (77%) primary care practices that were affiliated with a managed care organization offering a mailed FOBT program for patients aged >/=50 years. Of these 318 practices, 212 (67%) had 602 FOBT+ patients from August through November 1998. We studied 184 (87%) of these 212 practices with 490 FOBT+ patients after excluding those judged ineligible for a CDE or without demographic data. Three months after notification of the FOBT+ result, physicians were asked on audit forms if they had ordered CDEs for study patients. Patient- and physician-predictors of ordering CDEs were identified using logistic regression.
MEASUREMENTS AND MAIN RESULTS: A CDE was ordered for only 69.5% of 490 FOBT+ patients. After adjustment, women were less likely to have had CDE initiated than men (adjusted odds, 0.66; confidence interval, 0.44 to 0.97). Physician survey responses indicating intermediate or high intention to evaluate a FOBT+ patient with a CDE were associated with nearly 2-fold greater adjusted odds of actually initiating a CDE in this circumstance versus physicians with a low intention.
CONCLUSIONS: Primary care physicians often fail to order CDE for FOBT+ patients. A CDE was less likely to be ordered for women and was influenced by physician's beliefs about CDEs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12795734      PMCID: PMC1494867          DOI: 10.1046/j.1525-1497.2003.20525.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  28 in total

1.  It won't happen to me: lower perception of heart disease risk among women with family histories of breast cancer.

Authors:  J Erblich; D H Bovbjerg; C Norman; H B Valdimarsdottir; G H Montgomery
Journal:  Prev Med       Date:  2000-12       Impact factor: 4.018

2.  Colorectal cancer screening participation by older women.

Authors:  M T Mandelson; S J Curry; L A Anderson; M R Nadel; N C Lee; C M Rutter; A Z LaCroix
Journal:  Am J Prev Med       Date:  2000-10       Impact factor: 5.043

3.  The effect of fecal occult-blood screening on the incidence of colorectal cancer.

Authors:  J S Mandel; T R Church; J H Bond; F Ederer; M S Geisser; S J Mongin; D C Snover; L M Schuman
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

4.  Effects of information framing on the intentions of family physicians to prescribe long-term hormone replacement therapy.

Authors:  J Nikolajevic-Sarunac; D A Henry; D L O'Connell; J Robertson
Journal:  J Gen Intern Med       Date:  1999-10       Impact factor: 5.128

5.  Factors that influence the decision to do an adequate evaluation of a patient with a positive stool for occult blood.

Authors:  H M Shields; M S Weiner; D R Henry; J A Lloyd; B J Ransil; D A Lamphier; D W Gallagher; D A Antonioli; B A Rosner
Journal:  Am J Gastroenterol       Date:  2001-01       Impact factor: 10.864

6.  Physician intention to recommend complete diagnostic evaluation in colorectal cancer screening.

Authors:  R E Myers; T Hyslop; M Gerrity; N Schlackman; N Hanchak; J Grana; B J Turner; D Weinberg; W W Hauck
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-07       Impact factor: 4.254

Review 7.  Educational outreach visits: effects on professional practice and health care outcomes.

Authors:  M A Thomson O'Brien; A D Oxman; D A Davis; R B Haynes; N Freemantle; E L Harvey
Journal:  Cochrane Database Syst Rev       Date:  2000

8.  Colorectal cancer screening and surveillance practices by primary care physicians: results of a national survey.

Authors:  V K Sharma; R Vasudeva; C W Howden
Journal:  Am J Gastroenterol       Date:  2000-06       Impact factor: 10.864

9.  Cardiology services after stress testing: are there sex differences? A population-based study.

Authors:  S C Daly; V L Roger; C Leibson; T D Miller; P A Pellikka; K Bailey; S J Jacobsen
Journal:  J Clin Epidemiol       Date:  2000-07       Impact factor: 6.437

10.  Are there gender differences in starting protease inhibitors, HAART, and disease progression despite equal access to care?

Authors:  A Mocroft; M J Gill; W Davidson; A N Phillips
Journal:  J Acquir Immune Defic Syndr       Date:  2000-08-15       Impact factor: 3.731

View more
  25 in total

1.  Effectiveness of a provider reminder on fecal occult blood test follow-up.

Authors:  Meaghan F Larson; Cynthia W Ko; Jason A Dominitz
Journal:  Dig Dis Sci       Date:  2009-03-03       Impact factor: 3.199

2.  Patient-provider communication in cancer screening.

Authors:  Tung T Nguyen; Stephen J McPhee
Journal:  J Gen Intern Med       Date:  2003-05       Impact factor: 5.128

3.  Young adults' experiences with cancer: comments from patients and survivors.

Authors:  Baukje Bo Miedema; Julie Easley; Ryan Hamilton
Journal:  Can Fam Physician       Date:  2006-11       Impact factor: 3.275

4.  Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium.

Authors:  Anna N A Tosteson; Elisabeth F Beaber; Jasmin Tiro; Jane Kim; Anne Marie McCarthy; Virginia P Quinn; V Paul Doria-Rose; Cosette M Wheeler; William E Barlow; Mackenzie Bronson; Michael Garcia; Douglas A Corley; Jennifer S Haas; Ethan A Halm; Aruna Kamineni; Carolyn M Rutter; Tor D Tosteson; Amy Trentham-Dietz; Donald L Weaver
Journal:  J Gen Intern Med       Date:  2016-04       Impact factor: 5.128

5.  Gender disparities in colorectal cancer screening: true or false?

Authors:  Rachel A Callcut; Stephanie Kaufman; Robert Stone-Newsom; Patrick Remington; David Mahvi
Journal:  J Gastrointest Surg       Date:  2006-12       Impact factor: 3.452

Review 6.  Factors in quality care--the case of follow-up to abnormal cancer screening tests--problems in the steps and interfaces of care.

Authors:  Jane Zapka; Stephen H Taplin; Rebecca Anhang Price; Caroline Cranos; Robin Yabroff
Journal:  J Natl Cancer Inst Monogr       Date:  2010

7.  Contribution of patient, physician, and environmental factors to demographic and health variation in colonoscopy follow-up for abnormal colorectal cancer screening test results.

Authors:  Melissa R Partin; Amy A Gravely; James F Burgess; David A Haggstrom; Sarah E Lillie; David B Nelson; Sean M Nugent; Aasma Shaukat; Shahnaz Sultan; Louise C Walter; Diana J Burgess
Journal:  Cancer       Date:  2017-05-11       Impact factor: 6.860

8.  Patient and physician reminders to promote colorectal cancer screening: a randomized controlled trial.

Authors:  Thomas D Sequist; Alan M Zaslavsky; Richard Marshall; Robert H Fletcher; John Z Ayanian
Journal:  Arch Intern Med       Date:  2009-02-23

9.  Diagnostic resolution of cancer screening abnormalities at community health centers.

Authors:  Richard G Roetzheim; Ji-Hyun Lee; Ercilia R Calcano; Cathy D Meade; William J Fulp; Kristen J Wells
Journal:  J Health Care Poor Underserved       Date:  2012-08

10.  Using a multifaceted approach to improve the follow-up of positive fecal occult blood test results.

Authors:  Hardeep Singh; Himabindu Kadiyala; Gayathri Bhagwath; Anila Shethia; Hashem El-Serag; Annette Walder; Maria E Velez; Laura A Petersen
Journal:  Am J Gastroenterol       Date:  2009-03-17       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.